In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Horizon Pharma, Inc.
What else is new.
Horizon's nueromuscular disorder treatment trials failed.
Shares spiraled downward in early trading, but Mizuho's Irina Koffler expects the stock will plateau by the end of the day.
Cramer says FedEx will have a merry holiday season but he's avoiding Seaspan.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.